aid: wugen name: Wugen description: 'Wugen, Inc. is a St. Louis, Missouri clinical-stage cell-therapy company founded in 2018 out of Washington University in St. Louis that develops off-the-shelf, allogeneic CAR-T and memory NK cell therapies for blood cancers, using CRISPR deletion of the T-cell receptor so cells from healthy donors can be given without graft-versus-host disease. In July 2026 the company renamed itself Allotera Therapeutics, Inc. and moved to alloteratx.com, closing a $35M financing that brought total capital raised to roughly $150M on top of its $115M Series C; its lead program, soficabtagene geleucel (sofi-cel, formerly WU-CART-007), is a CD7-targeted allogeneic CAR-T in a global pivotal study for relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, holds FDA Breakthrough Therapy designation, and was selected for the FDA CMC Development and Readiness Pilot Program. Wugen/Allotera publishes no product or developer API, no OpenAPI, no llms.txt and no agent card. The only machine-readable surface either domain exposes is the WordPress REST API (wp/v2), anonymously readable on both the current alloteratx.com site and the retired wugen.com brand domain, which still serves the complete historical press-release and scientific-publication archive as JSON even though its human-facing site is now a single splash page.' url: https://raw.githubusercontent.com/api-evangelist/wugen/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enrichment-pipeline image: https://alloteratx.com/wp-content/uploads/2026/06/Asset-1.svg specificationVersion: '0.20' created: '2026-08-05' modified: '2026-08-05' tags: - Company - Biotechnology - Cell Therapy - Oncology - Life Sciences - Pharmaceuticals - Clinical Trials - CAR-T - CRISPR - Immunotherapy - Research - Content apis: - aid: wugen:wugen-comments-api name: Wugen Comments API description: The Comments API from Wugen — 2 operation(s) for comments. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Comments properties: - type: OpenAPI url: openapi/wugen-comments-api-openapi.yml - aid: wugen:wugen-discovery-api name: Wugen Discovery API description: The Discovery API from Wugen — 7 operation(s) for discovery. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Discovery properties: - type: OpenAPI url: openapi/wugen-discovery-api-openapi.yml - aid: wugen:wugen-media-api name: Wugen Media API description: The Media API from Wugen — 2 operation(s) for media. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Media properties: - type: OpenAPI url: openapi/wugen-media-api-openapi.yml - aid: wugen:wugen-pages-api name: Wugen Pages API description: The Pages API from Wugen — 2 operation(s) for pages. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Pages properties: - type: OpenAPI url: openapi/wugen-pages-api-openapi.yml - aid: wugen:wugen-posts-api name: Wugen Posts API description: The Posts API from Wugen — 2 operation(s) for posts. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Posts properties: - type: OpenAPI url: openapi/wugen-posts-api-openapi.yml - aid: wugen:wugen-search-api name: Wugen Search API description: The Search API from Wugen — 1 operation(s) for search. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Search properties: - type: OpenAPI url: openapi/wugen-search-api-openapi.yml - aid: wugen:wugen-taxonomy-api name: Wugen Taxonomy API description: The Taxonomy API from Wugen — 4 operation(s) for taxonomy. humanURL: https://alloteratx.com/press-releases/ baseURL: https://alloteratx.com/wp-json/wp/v2 tags: - Taxonomy properties: - type: OpenAPI url: openapi/wugen-taxonomy-api-openapi.yml x-enrichment: date: '2026-08-05' status: enriched artifacts_added: 21 pass: local-v1 maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Overlay url: overlays/wugen-allotera-content-overlay.yaml - type: AgenticAccess url: agentic-access/wugen-agentic-access.yml - type: DomainSecurity url: security/wugen-domain-security.yml - type: Authentication url: authentication/wugen-authentication.yml - type: Conventions url: conventions/wugen-conventions.yml - type: Conformance url: conformance/wugen-conformance.yml - type: Lifecycle url: lifecycle/wugen-lifecycle.yml - type: ErrorCatalog url: errors/wugen-problem-types.yml - type: DataModel url: data-model/wugen-data-model.yml - type: Examples url: examples/wugen-examples.yml - type: WellKnown url: well-known/wugen-well-known.yml - type: LLMsTxt url: llms/wugen-llms.txt - type: AgentSkill url: skills/_index.yml - type: Website url: https://alloteratx.com/ - type: BlogRSS url: https://alloteratx.com/feed/ - type: FormerWebsite url: https://wugen.com/ - type: About url: https://alloteratx.com/about-us/ - type: Technology url: https://alloteratx.com/science/ - type: Pipeline url: https://alloteratx.com/pipeline/ - type: News url: https://alloteratx.com/press-releases/ - type: Publications url: https://alloteratx.com/scientific-publications/ - type: Team url: https://alloteratx.com/leadership/ - type: Board url: https://alloteratx.com/board-of-directors/ - type: Investors url: https://alloteratx.com/investors/ - type: Partners url: https://alloteratx.com/partners/ - type: Careers url: https://alloteratx.com/career-opportunities/ - type: Support url: https://alloteratx.com/contact-us/ - type: PrivacyPolicy url: https://alloteratx.com/privacy-notice/ - type: Accessibility url: https://alloteratx.com/accessibility/ - type: LinkedIn url: https://www.linkedin.com/company/wugen - type: SecondaryMarket url: https://forgeglobal.com/wugen_stock/